NO149999C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.

Info

Publication number
NO149999C
NO149999C NO792507A NO792507A NO149999C NO 149999 C NO149999 C NO 149999C NO 792507 A NO792507 A NO 792507A NO 792507 A NO792507 A NO 792507A NO 149999 C NO149999 C NO 149999C
Authority
NO
Norway
Prior art keywords
retinamides
acyloxyphenyl
trans
preparation
therapeutic effective
Prior art date
Application number
NO792507A
Other languages
English (en)
Other versions
NO149999B (no
NO792507L (no
Inventor
Robert J Gander
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of NO792507L publication Critical patent/NO792507L/no
Publication of NO149999B publication Critical patent/NO149999B/no
Publication of NO149999C publication Critical patent/NO149999C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO792507A 1978-07-31 1979-07-30 Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider. NO149999C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/929,093 US4310546A (en) 1978-07-31 1978-07-31 Novel retinoids and their use in preventing carcinogenesis

Publications (3)

Publication Number Publication Date
NO792507L NO792507L (no) 1980-02-01
NO149999B NO149999B (no) 1984-04-24
NO149999C true NO149999C (no) 1984-08-01

Family

ID=25457311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792507A NO149999C (no) 1978-07-31 1979-07-30 Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.

Country Status (14)

Country Link
US (1) US4310546A (no)
AT (1) AT367032B (no)
BE (1) BE877976A (no)
CA (1) CA1108170A (no)
CH (1) CH644845A5 (no)
DE (1) DE2930923A1 (no)
DK (1) DK324279A (no)
FR (1) FR2432509A1 (no)
GB (1) GB2026493B (no)
IE (1) IE48304B1 (no)
IT (1) IT1162414B (no)
NL (1) NL7905893A (no)
NO (1) NO149999C (no)
SE (1) SE442011B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456663A (en) * 1984-05-25 1995-10-10 Lemelson; Jerome H. Drugs and methods for treating diseases
US4665098A (en) * 1985-03-28 1987-05-12 Mcneilab, Inc. Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
ES2095207T3 (es) * 1987-12-16 1997-02-16 Pasteur Institut Receptor de acido retinoico y derivados del mismo, adn que codifica cualquiera de las dos sustancias y uso de las proteinas y del adn.
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
US5849595A (en) * 1992-10-05 1998-12-15 Alfano; Robert R. Method for monitoring the effects of chemotherapeutic agents on neoplasmic media
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
KR100508627B1 (ko) * 2001-05-29 2005-08-17 (주)케비젠 신규한 레티노이드 유도체 및 이의 제조방법 및 그화합물을 함유한 항암제 조성물
WO2002096857A1 (en) * 2001-05-29 2002-12-05 Chebigen Co., Ltd. Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds
WO2005072091A2 (en) * 2003-12-09 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods for inhibiting hiv and other viral infections by modulating ceramide metabolism
WO2005079774A2 (en) * 2004-02-17 2005-09-01 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
US7566808B2 (en) * 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
EA010827B1 (ru) 2004-12-08 2008-12-30 Сирион Терапьютикс, Инк. Композиции для лечения ретинол-ассоциированных заболеваний
KR20060094745A (ko) * 2005-02-25 2006-08-30 (주)나노하이브리드 층상형 금속 수산화물과 레티노익산의 혼성체를 함유하는암치료용 약학적 조성물
TW200829269A (en) * 2007-01-12 2008-07-16 Koyo Internat Holding Corp Methods for the cultivation of DC/D-CIK cells and applications
CN101591280B (zh) * 2008-05-30 2012-08-22 安徽医科大学 具有肿瘤诱导分化作用的类维甲酸衍生物及其药物组合物与用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH529742A (de) * 1970-02-02 1972-10-31 Hoffmann La Roche Verfahren zur Herstellung von Vitamin-A-Säureamiden
DE2300107C2 (de) * 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid

Also Published As

Publication number Publication date
SE442011B (sv) 1985-11-25
CH644845A5 (de) 1984-08-31
IE48304B1 (en) 1984-11-28
CA1108170A (en) 1981-09-01
GB2026493B (en) 1982-09-29
NO149999B (no) 1984-04-24
IE791441L (en) 1980-01-31
IT7949884A0 (it) 1979-07-27
SE7906365L (sv) 1980-02-01
NO792507L (no) 1980-02-01
DE2930923A1 (de) 1980-02-21
FR2432509A1 (fr) 1980-02-29
GB2026493A (en) 1980-02-06
AT367032B (de) 1982-05-25
ATA522979A (de) 1981-10-15
BE877976A (fr) 1980-01-30
DK324279A (da) 1980-02-01
IT1162414B (it) 1987-04-01
NL7905893A (nl) 1980-02-04
FR2432509B1 (no) 1984-03-30
US4310546A (en) 1982-01-12

Similar Documents

Publication Publication Date Title
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO149999C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO151964C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(4-pipieridyl)-propaner
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
FI793367A (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-yl-urinaemnen
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser